Allogene

Allogene set to disrupt CAR-T market with pivotal trial of ‘off the shelf’ therapy

https://pharmaphorum.com/news/allogene-announces-pivotal-trial/

Century gets $250m to develop next-gen ‘off the shelf’ cancer cell therapies

https://pharmaphorum.com/news/century-gets-250m-to-develop-next-gen-off-the-shelf-cancer-cell-therapies/

Allogene raises another $120m to develop ‘off-the-shelf’ CAR-Ts

https://pharmaphorum.com/news/allogene-raises-another-120m-to-develop-off-the-shelf-car-ts/

Ex-Kite chiefs’ biotech to research ‘off-the-shelf’ CAR-Ts with Cellectis

https://pharmaphorum.com/news/ex-kite-chiefs-biotech-research-off-shelf-car-ts-cellectis/

Close in 10 seconds

Pharmaphorum.com

Search